I. [Product Description]
Fe3O4-CD206 Ab-PLGA NPs, which are poly(lactic-glycolic acid) (PLGA) nanoparticles loaded with Fe3O4 and conjugated with CD206 antibody, are important organic intermediates. Its unique nanoparticle structure combines the characteristics of CD206 antibody and Fe3O4, providing new materials and ideas for research in related fields.

II. [Product Details]
【Appearance】Depending on different molecular weights, it appears as a white/off-white solid or a viscous liquid.
【Stability】Store it under refrigeration and avoid repeated freezing and thawing.
【Solvent】Common organic solvents such as chloroform and DMSO.
【Storage Conditions】Store it in a sealed and dry place at a low temperature below 4°C.
▪ Precautions: ▶ To ensure product stability, please open the package for use after constant-temperature drying!

III. [Application Fields]
1. It can be used for carrier construction in nanomaterial research.
2. As a component of new composite materials.
3. For signal enhancement in the field of biosensing.
4. Applied to the adsorption research of specific substances in environmental science.
5. As a catalyst carrier in catalytic reactions.

Note: The products sold by our company are only for scientific research and cannot be used in human experiments or human treatment.

Chongqing Yusi Pharmaceutical Technology Co., Ltd. operates based on an integrated business model of independent R & D, production, and sales, providing professional scientific research reagents for university scientific research experiments. Compared with similar products on the market, our company's products have obvious price advantages. In addition, we also provide professional product customization services.

If you have other product needs, please contact us:
Contact Information:
Landline: 023-62795528
Customer Service Hotline: 19923757617 丨 QQ: 3279537175
                                           19112925095 丨 QQ: 3012135199

Recommended Similar Products:
1. Fe3O4-PLGA NPs, poly(lactic-glycolic acid) (PLGA) nanoparticles loaded with Fe3O4
2. CD206 Ab-PLGA NPs, poly(lactic-glycolic acid) (PLGA) nanoparticles conjugated with CD206 antibody
3. Fe3O4-CD208 Ab-PLGA NPs, poly(lactic-glycolic acid) (PLGA) nanoparticles loaded with Fe3O4 and conjugated with CD208 antibody
4. Fe3O4-CD210 Ab-PLGA NPs, poly(lactic-glycolic acid) (PLGA) nanoparticles loaded with Fe3O4 and conjugated with CD210 antibody
5. Fe3O4-CD212 Ab-PLGA NPs, poly(lactic-glycolic acid) (PLGA) nanoparticles loaded with Fe3O4 and conjugated with CD212 antibody
6. Fe3O4-CD214 Ab-PLGA NPs, poly(lactic-glycolic acid) (PLGA) nanoparticles loaded with Fe3O4 and conjugated with CD214 antibody
7. Fe3O4-CD216 Ab-PLGA NPs, poly(lactic-glycolic acid) (PLGA) nanoparticles loaded with Fe3O4 and conjugated with CD216 antibody
8. Fe3O4-CD218 Ab-PLGA NPs, poly(lactic-glycolic acid) (PLGA) nanoparticles loaded with Fe3O4 and conjugated with CD218 antibody
9. Fe3O4-CD220 Ab-PLGA NPs, poly(lactic-glycolic acid) (PLGA) nanoparticles loaded with Fe3O4 and conjugated with CD220 antibody
10. Fe3O4-CD222 Ab-PLGA NPs, poly(lactic-glycolic acid) (PLGA) nanoparticles loaded with Fe3O4 and conjugated with CD222 antibody
11. Fe3O4-CD224 Ab-PLGA NPs, poly(lactic-glycolic acid) (PLGA) nanoparticles loaded with Fe3O4 and conjugated with CD224 antibody
12. Fe3O4-CD226 Ab-PLGA NPs, poly(lactic-glycolic acid) (PLGA) nanoparticles loaded with Fe3O4 and conjugated with CD226 antibody